Superstring Capital Management LP Bridge Bio Pharma, Inc. Transaction History
Superstring Capital Management LP
- $115 Billion
- Q4 2024
A detailed history of Superstring Capital Management LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Superstring Capital Management LP holds 262,141 shares of BBIO stock, worth $8.23 Million. This represents 6.23% of its overall portfolio holdings.
Number of Shares
262,141
Previous 226,684
15.64%
Holding current value
$8.23 Million
Previous $5.77 Billion
24.63%
% of portfolio
6.23%
Previous 5.05%
Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$793 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$789 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$473 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$391 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$194 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.65B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...